SYMPLICITY HTN-3 (2014) — Trial Summary

SYMPLICITY HTN-3 (2014): Prospective, single-blind, randomized, sham-controlled trial of catheter-based renal artery denervation versus a sham procedure in adults with resistant hypertension on stable, maximally tolerated antihypertensive therapy (NCT01418261). Primary efficacy outcome: change in of

References

NephroResource

Taking longer than expected

If you're on a slow connection or this keeps happening, tap below to reload.